Characteristics, treatment patterns, and prognostic factors in small cell lung cancer transformation of advanced non-small cell lung cancer with epidermal growth factor receptor mutation after tyrosine kinase inhibitor therapy

被引：0
|
作者：
Liao, Ying-Ting
Chiang, Chi-Lu
Sun, Ruei-Lin
Yeh, Yi-chen
Huang, Hsu-Ching
Shen, Chia-I
Tseng, Yen-Han
Luo, Yung-Hung
Chen, Yuh-Min
Whang-Peng, Jacqueline
机构：
[1] Taipei Vet Gen Hosp, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan
[3] Taipei Med Univ, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20569
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Role of Mutation Status of the Epidermal Growth Factor Receptor Gene In Advanced Non-Small Cell Lung Cancer
    Vaguliene, Neringa
    Zemaitis, Marius
    Sarauskas, Valdas
    Vitkauskiene, Astra
    Miliauskas, Skaidrius
    MEDICINA-LITHUANIA, 2012, 48 (04): : 175 - 181
  • [42] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib
    Morin-Ben Abdallah, Sami
    Hirsh, Vera
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [43] Targeted therapy for the treatment of advanced non-small cell lung cancer - A review of the epidermal growth factor receptor antagonists
    Silvestri, GA
    Rivera, MP
    CHEST, 2005, 128 (06) : 3975 - 3984
  • [44] TREATMENT OF LEPTOMENINGEAL METASTASIS FROM NON-SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS
    Nanjo, S.
    Katakami, N.
    Otsuka, K.
    Tachikawa, R.
    Hata, A.
    Otsuka, K.
    Kaji, R.
    Fujita, S.
    Hayashi, M.
    Tomii, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 142 - 142
  • [45] Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Wright, Natalie M. Andrews
    Goss, Glenwood D.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S247 - S264
  • [46] Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review
    Imakita, Takuma
    Matsumoto, Hirotaka
    Hirano, Katsuya
    Morisawa, Toshiyuki
    Sakurai, Azusa
    Kataoka, Yuki
    BMC CANCER, 2019, 19 (1)
  • [47] Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review
    Takuma Imakita
    Hirotaka Matsumoto
    Katsuya Hirano
    Toshiyuki Morisawa
    Azusa Sakurai
    Yuki Kataoka
    BMC Cancer, 19
  • [48] Strategies and influencing factors for the treatment of advanced non-small cell lung cancer based on epidermal growth factor receptor tyrosine kinase inhibitors: a narrative review
    Kuang, Linwu
    Wang, Peng
    Zhou, Lin
    Li, Yangkai
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (09) : 5123 - 5140
  • [49] A Comprehensive Review of Epidermal Growth Factor Receptor Mutation Abundance in Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors
    Zeng, Linmiao
    Dai, Yiqun
    Liu, Yuting
    Song, Bin
    Lin, Hui
    Xiao, Jianhong
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (12)
  • [50] Targeting mTOR to Overcome Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cells
    Fei, Shi-Jiang
    Zhang, Xu-Chao
    Dong, Song
    Cheng, Hua
    Zhang, Yi-Fang
    Huang, Ling
    Zhou, Hai-Yu
    Xie, Zhi
    Chen, Zhi-Hong
    Wu, Yi-Long
    PLOS ONE, 2013, 8 (07):
12345